INSILENS, A Noetera Company

Biotech Intelligence Platform

Turn Global Biotech Signals, Into Strategic Intelligence

Explore with us

Biotech Signals. Structured for Decisions.

INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.

Deals and Financing
Therapeutic Indication
Technology Modalities
View all

Weekly Market Insight

Gilead – $5B Tubulis Acquisition
BMS – Anthropic AI Partnership
Pfizer – SF R&D Site Closure
Waypoint Bio – China IIT CAR-T Strategy